Home » Posts tagged with » Mark Mintun
Reyvow CENTURION trial results : Lilly migraine drug succeeds in phase 3 study

Reyvow CENTURION trial results : Lilly migraine drug succeeds in phase 3 study

Reyvow CENTURION trial results : Eli Lilly and Company (Lilly) said that its migraine drug Reyvow (lasmiditan) has met the co-primary endpoint of a phase 3 clinical trial called CENTURION by delivering pain freedom from migraine attacks at 60 minutes and up to 48 hours. According to the US pharma giant, adults who were given Reyvow […]